PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Epidemiology and Health Statistics,School of Public Health, Fujian Medical University, Fuzhou, China.\', \'Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, China.\', \'Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fujian Province, Fuzhou, China.\', \'Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Malmö, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7554/eLife.73873e73873
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 34866576
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all